SIEBERT JOHN M
SEC CIK 1190558 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Dir | 87.9K | — | — | 4 | 2021-08-11 | 2024-02-23 |
Most active insiders at SUPN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Khattar Jack A. | Pres, CEO, Dir | — | $7.72M |
| 2 | Bhatt Padmanabh P. | CSO, SVP of IP | — | $5.42M |
| 3 | NEWHALL CHARLES W III | Dir | — | $1.27M |
| 4 | Mottola Frank | SVP, Chief Tech. Ops. Off | — | $1.10M |
| 5 | GEMAYEL GEORGES | Dir | — | $1.00M |
| 6 | Horich William Todd | SVP, Commercial Ops | — | $483.8K |
| 7 | Hudson Frederick M. | Dir | — | $271.7K |
| 8 | Sensenig Bethany | Dir | — | $228.3K |
| 9 | Rubin Jonathan | SVP, Chief Medical Off | — | — |
| 10 | Barlow Carrolee | Dir | — | — |
SIEBERT JOHN M made no open-market trades at SUPN in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-27 | 2024-02-23 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | SIEBERT JOHN M | Dir | A - Grant | $0.00 | +3,886 | 87.9K | +5% | $0 |
| D | 2023-02-24 | 2023-02-22 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | SIEBERT JOHN M | Dir | A - Grant | $0.00 | +3,882 | 84.1K | +5% | $0 |
| D | 2022-02-23 | 2022-02-19 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | SIEBERT JOHN M | Dir | A - Grant | $0.00 | +4,222 | 80.2K | +6% | $0 |
| D | 2021-08-12 | 2021-08-11 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | SIEBERT JOHN M | Dir | M - OptEx | $12.98 | +15.0K | 76.0K | +25% | +$194.7K |
Purchase Sale Sale after option exercise All abbreviations